CY1110173T1 - Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης - Google Patents

Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης

Info

Publication number
CY1110173T1
CY1110173T1 CY20091100116T CY091100116T CY1110173T1 CY 1110173 T1 CY1110173 T1 CY 1110173T1 CY 20091100116 T CY20091100116 T CY 20091100116T CY 091100116 T CY091100116 T CY 091100116T CY 1110173 T1 CY1110173 T1 CY 1110173T1
Authority
CY
Cyprus
Prior art keywords
estra
benzodioxol
dien
propynyl
hydroxy
Prior art date
Application number
CY20091100116T
Other languages
English (en)
Inventor
Cornelis Sennef
Bwmm Bernardus Peeters
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1110173T1 publication Critical patent/CY1110173T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αφορά στη χρήση του ανταγωνιστή υποδοχέων των γλυκοκορτικοειδών (11β, 17β)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl) estra- 4,9-dien-3-one (Org 34517) για την παρασκευή ενός φαρμάκου για τη θεραπεία της κατάθλιψης καθώς επίσης σε φαρμακευτικές παρασκευές της Org 34517 για την εν λόγω χρήση.
CY20091100116T 2001-10-26 2009-02-02 Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης CY1110173T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204072 2001-10-26
EP06101005A EP1652526B1 (en) 2001-10-26 2002-10-21 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder

Publications (1)

Publication Number Publication Date
CY1110173T1 true CY1110173T1 (el) 2015-01-14

Family

ID=8181136

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100116T CY1110173T1 (el) 2001-10-26 2009-02-02 Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης

Country Status (27)

Country Link
US (1) US20040266863A1 (el)
EP (2) EP1441739B1 (el)
JP (1) JP4647909B2 (el)
KR (1) KR20050038580A (el)
CN (1) CN100531738C (el)
AT (2) ATE420649T1 (el)
AU (1) AU2002348996B2 (el)
BR (1) BR0213466A (el)
CA (1) CA2463446C (el)
CY (1) CY1110173T1 (el)
DE (2) DE60209248D1 (el)
DK (1) DK1652526T3 (el)
EC (1) ECSP045080A (el)
ES (1) ES2319563T3 (el)
HK (1) HK1087357A1 (el)
HR (1) HRP20040370B1 (el)
HU (1) HUP0500070A3 (el)
IL (2) IL161248A0 (el)
IS (1) IS2702B (el)
MX (1) MXPA04003781A (el)
NO (1) NO332978B1 (el)
NZ (1) NZ532429A (el)
PL (1) PL206687B1 (el)
PT (1) PT1652526E (el)
RU (1) RU2302245C2 (el)
WO (1) WO2003037354A1 (el)
ZA (1) ZA200403088B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
EP1814589B1 (en) * 2004-11-19 2015-04-15 MSD Oss B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
CA2649894A1 (en) * 2006-05-02 2007-11-15 Corcept Therapeutics, Inc. The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2
JP5804395B2 (ja) * 2011-02-03 2015-11-04 ポップ テスト オンコロジー エルエルシー 診断と治療のためのシステムおよび方法
US20120263660A1 (en) * 2011-04-18 2012-10-18 Pop Test Cortisol Llc Hair Loss Treatment
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
WO1999017779A1 (en) * 1997-10-06 1999-04-15 The Board Of Trustees Of Leland Stanford Jr. University Methods for treating psychosis associated with glucocorticoid related dysfunction
KR100895662B1 (ko) * 2001-03-23 2009-05-07 코어셉트 쎄라퓨틱스, 잉크. 글루코코르티코이드 수용체 특이적 길항제를 이용한스트레스 장애의 치료 방법
DE60238671D1 (de) * 2001-05-04 2011-02-03 Corcept Therapeutics Inc Verwendung von glucocorticoid-rezeptor-spezifischen antagonisten zur behandlung von delirium
KR20040029116A (ko) * 2001-08-31 2004-04-03 코어셉트 쎄라퓨틱스, 잉크. 다운 증후군에 걸린 성인에서의 인지 장애 억제 방법

Also Published As

Publication number Publication date
BR0213466A (pt) 2004-11-09
DE60230936D1 (de) 2009-03-05
IL161248A0 (en) 2004-09-27
CA2463446C (en) 2010-02-23
AU2002348996B2 (en) 2008-06-05
EP1652526A2 (en) 2006-05-03
IS2702B (is) 2010-11-15
IS7204A (is) 2004-03-31
CN1582153A (zh) 2005-02-16
HRP20040370A2 (en) 2004-08-31
HUP0500070A3 (en) 2012-09-28
KR20050038580A (ko) 2005-04-27
EP1652526B1 (en) 2009-01-14
PL206687B1 (pl) 2010-09-30
IL161248A (en) 2010-12-30
WO2003037354A1 (en) 2003-05-08
CN100531738C (zh) 2009-08-26
HK1087357A1 (en) 2006-10-13
ATE420649T1 (de) 2009-01-15
NZ532429A (en) 2004-10-29
JP4647909B2 (ja) 2011-03-09
DK1652526T3 (da) 2009-05-18
JP2005521637A (ja) 2005-07-21
ES2319563T3 (es) 2009-05-08
RU2004116082A (ru) 2005-05-10
HRP20040370B1 (en) 2012-09-30
PL369261A1 (en) 2005-04-18
MXPA04003781A (es) 2004-07-30
ATE317700T1 (de) 2006-03-15
CA2463446A1 (en) 2003-05-08
EP1652526A3 (en) 2006-08-02
EP1441739A1 (en) 2004-08-04
ECSP045080A (es) 2004-06-28
NO20041651L (no) 2004-04-23
RU2302245C2 (ru) 2007-07-10
ZA200403088B (en) 2005-01-24
PT1652526E (pt) 2009-02-06
DE60209248D1 (de) 2006-04-20
HUP0500070A2 (hu) 2005-04-28
US20040266863A1 (en) 2004-12-30
EP1441739B1 (en) 2006-02-15
NO332978B1 (no) 2013-02-11

Similar Documents

Publication Publication Date Title
CY1110173T1 (el) Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης
CY1104981T1 (el) Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων
CY1105632T1 (el) Θεραπεια αντικαταστασης ορμονων με χρηση ενος συνδυασμου συζευγμενων οιστρογονων και οξικης μεδροξυπρογεστερονης
HUP0301813A2 (hu) Nem-orális androgén szteroidok
DK0806952T3 (da) Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger
DE60309895D1 (de) Estrogenersatztherapie
DE502008002148D1 (de) Arzneimittel umfassend wenigstens ein gestagen
DK1443966T3 (da) Fremgangsmåde til forebyggelse eller behandling af benigne gynækologiske lidelser
CO5261567A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas
CY1105548T1 (el) Συνδυασμος του loteprednol και αγωνιστων του β2-αδρενοϋποδοχεως και η χρηση του με εισπνοες για την αγωγη του βρογχικου ασθματος
DK1487859T3 (da) Fremstillingsmetoder til at fremstille Eplerenon
ATE419855T1 (de) Therapie für hormonersatz und depression enthaltend dienogest
HUP9901474A2 (hu) Szekvenciális ösztrogén/progeszteron-antagonista kombináció hormonhelyettesítő terápiához
RS50350B (sr) Upotreba 11beta-(4-acetilfenil)-17beta-hidroksi-17alfa-(1,1,2,2,2-pentafluoretil)estra-4,9-dien-3-ona za pripremanje medikamenta za lečenje kancera dojke, jajnika, endometrijuma, mijeloma i meningioma
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
CY1112775T1 (el) Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος
CY1116194T1 (el) Σκευασμα οιστραδιολης-προγεστερονης βραδειας αποδeσμευσης
CY1110463T1 (el) Θεραπεια ορμονικης αντικαταστασης και καταθλιψης που περιλαμβανει διενογεστη
DK1910398T3 (da) 17-alfa-substituerede derivater af estradiol med sårhelende virkning